Aterian Sets Date for Third Quarter 2024 Earnings Announcement & Investor Conference CallGlobeNewsWire • 10/29/24
Aterian Sets Date for Second Quarter 2024 Earnings Announcement & Investor Conference CallGlobeNewsWire • 07/29/24
Aterian Announces Leadership Changes & Improved Second Quarter 2024 Net Revenue and Adjusted EBITDA RangesGlobeNewsWire • 06/26/24
Aterian Sets Date for First Quarter 2024 Earnings Announcement & Investor Conference CallGlobeNewsWire • 04/25/24
Aterian Announces Improved First Quarter 2024 Net Revenue and Adjusted EBITDA RangesGlobeNewsWire • 04/22/24
Aterian Investment Partners to Recapitalize CPL, a Leading Pharmaceutical Contract Development and Manufacturing OrganizationBusiness Wire • 04/01/24
Aterian Sets Date for Fourth Quarter & Full Year 2023 Earnings Announcement & Investor Conference CallGlobeNewsWire • 02/29/24
Aterian Further Strengthens Its Balance Sheet With Extension Of Its Credit FacilityGlobeNewsWire • 02/26/24
Aterian Announces Fixed Cost Reduction Plan and Preliminary Fourth Quarter 2023 ResultsGlobeNewsWire • 02/14/24
Aterian Sets Date for Third Quarter 2023 Earnings Announcement & Investor Conference CallGlobeNewsWire • 10/27/23
Aterian Receives Extension To Regain Compliance With Nasdaq Minimum Bid Price RuleGlobeNewsWire • 10/24/23